Time to standardize reporting of surgical margin data after radical prostatectomy?

It’s been a while since we last discussed the reporting of surgical margin status after radical prostatectomy and the prognostic value of positive surgical margins in determination of who would be wise to consider immediate, adjuvant radiation therapy as opposed to waiting until the need for salvage radiation therapy became evident. … READ MORE …

Immediate adjuvant radiation therapy in the pT3 patient post-surgery

In March 2009, Thompson et al. published data from the SWOG 8794 trial showing that adjuvant radiation therapy immediately post-surgery significantly improved the oncologic outcomes of men with pathologic T3N0M0 prostate cancer compared to later salvage radiation, but … READ MORE …

Prostate cancer news reports: Monday, March 29, 2010

News reports over the weekend included:

  • Various review articles dealing with such matters as Gleason grading, numbers of cores taken at biopsy, the need for lymph node dissection, surgical technique and surgical margin control, and cryotherapy
  • The effect of a water extract of white cocoa tea on prostate cancer cells in vitro and in a mouse model … READ MORE …

Prostate cancer news reports: Thursday, July 2, 2009

Today’s news reports discuss such issues as:

  • Sextant biopsy in diagnosis of unilateral prostate cancer
  • Aggressiveness of prostate cancer in man diagnosed with PSA < 4 ng/ml
  • The potential of 3T MRI in prostate cancer prognosis pre-surgery
  • Surgical margins and risk for biochemical recurrence post-surgery … READ MORE …

Wednesday’s news: October 15, 2008

There is a significant number of new reports today, addressing such issues as: data from a large series of robotic prostatectomy patients; the importance of positive surgical margins and their management; the significance of number of positive lymph nodes in N+M0 patients; evolving models of the role of testosterone in prostate cancer progression; and data on the clinical use of the investigational LHRH antagonist degarelix. … READ MORE …